TruAlt Bioenergy
MAINBOARD
Listed
Price Band
₹472 - ₹496
Lot Size
30 Shares
Issue Size
₹89.28 Cr
Fresh Issue
Nil (Pure OFS)
OFS
₹89.28 Cr (Full Issue)
Registrar
Bigshare Services Private Limited
AI Sentiment Score
Listing Price
₹545.00
vs Issue: ₹496 (+9.88%)
📅 IPO Timeline
✓
Open
Sep 25, 2025
✓
Close
Sep 29, 2025
✓
Allotment
Sep 30, 2025
✓
Refund
Oct 1, 2025
✓
Demat
Oct 1, 2025
✓
Listing
Oct 3, 2025
📈 Grey Market Premium (GMP) Trendline
Daily consensus GMP movement (₹) recorded across market sources
✨ AI Analysis & Prediction
🔒 Final Reconciled Estimate
Locked post-listing with actual debut performance
TruAlt Bioenergy displays an established operational footprint with expanding revenue streams (31.4% CAGR) and a defensible value proposition.
💪 Strengths
- Demonstrated operational revenue trajectory with resilient top-line growth (31.4% CAGR).
- Established customer relationships and market position across target industry sectors.
- Sound operational capital returns with Return on Capital Employed (ROCE) at 10.4%.
⚠️ Weaknesses
- Exposure to input cost fluctuations and broader macroeconomic supply chain cycles.
- Working capital requirements to support continuous capacity expansion.
- Competitive landscape from both established incumbents and specialized regional players.
🚀 Opportunities
- Industry tailwinds from rising domestic capex and infrastructure spending.
- Operating leverage potential allowing margin expansion as manufacturing utilization rises.
- Geographic diversification and entry into higher-margin specialized product lines.
🛡️ Threats
- Sectoral regulatory shifts and evolving statutory compliance requirements.
- Aggressive pricing actions by domestic competitors impacting gross margins.
- Broader market equity volatility and liquidity fluctuations.
📊 Financial Overview & Growth Trajectory
Multi-year operational scale & net profitability trajectory
| Metric | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue (₹ Cr) | Rs 762.00 Cr | Rs 1,223.00 Cr | Rs 1,908.00 Cr | Rs 1,728.00 Cr |
| Net Profit / PAT (₹ Cr) | Rs 35.00 Cr | Rs 32.00 Cr | Rs 147.00 Cr | Rs 97.00 Cr |
| EBITDA / Op. Profit (₹ Cr) | Rs 105.00 Cr | Rs 188.00 Cr | Rs 309.00 Cr | Rs 290.00 Cr |
| Borrowings (₹ Cr) | Rs 1,150.00 Cr | Rs 1,685.00 Cr | Rs 1,557.00 Cr | Rs 1,652.00 Cr |
| Total Assets (₹ Cr) | Rs 1,856.00 Cr | Rs 2,418.00 Cr | Rs 3,030.00 Cr | Rs 3,778.00 Cr |
| ROE % | 0.00% | 0.00% | 0.00% | 0.00% |
| ROCE % | 10.40% | 10.40% | 10.40% | 10.40% |
| Debt / Equity | 0.00 | 0.00 | 0.00 | 0.00 |
Company P/E
24.3x
Industry P/E
27.9x
Debt/Equity
1.09
⚖️ Valuation Benchmark Range
🟢 Attractively Priced vs Industry Peers
Industry 27.9x
IPO 24.3x
0x (Deep Value)
38x (High Multiple)
📋 Live Subscription Status
QIB
159.22x
NII
113.46x
Retail
11.00x
Total
71.92x
🎯 Retail Allotment Probability
9.1% Odds
1 in 11.0 chance (~9.1% probability per PAN)
SEBI Rule: Under SEBI lottery allotment rules, applying for multiple lots under Retail does NOT increase your lottery odds. All valid retail applicants have identical 1-lot odds per PAN.
Updated: Sep 12, 2026 2:35 PM
💼 Issue Structure & Reservation Quota
Capital Structure
₹89.3 Cr
Issue Size
OFS (100%)
Reservation Quota
100%
Allocation
QIB (50%)
NII (15%)
Retail (35%)
QIB
50.00%
Retail
35.00%
NII
15.00%
🔗 Important Links & Lead Managers
- SEBI Filings (DRHP)View on SEBI →
- SEBI Filings (RHP)View on SEBI →
Disclaimer: The information provided on this page is for educational and informational purposes only and does not constitute financial advice. IPO investments are subject to market risks. AI-generated analysis is based on publicly available data and may not be accurate. Grey Market Premium (GMP) is unofficial and highly speculative. Always consult a qualified financial advisor and read the DRHP/RHP carefully before making investment decisions.